Santhera Pharmaceuticals Holding AG insider transactions
Management transactions
2
Shareholding disclosures
393
First disclosure
02.11.2006
Last disclosure
10.09.2026
Company summary
No management purchase or sale disclosed in the last 90 days.
- Latest purchase
- CHF 277’493
- Net flow 90 d
- CHF 0.00
- Top shareholder
- 40.166%
18.01.2024 · Executive member of the board of directors / senior management
Buys − sales
Santhera Pharmaceuticals Holding AG
This page brings together all Santhera Pharmaceuticals Holding AG (SANPHAR) insider transactions: 2 management transactions and 393 significant shareholding disclosures published by SIX Exchange Regulation, from 02.11.2006 to 10.09.2026.
Detailed context
A total of 2 management transactions and 393 significant shareholding disclosures regarding Santhera Pharmaceuticals Holding AG have been published by SIX Exchange Regulation, which tracks official insider transactions. Over the last 90 days, there have been 0 purchases for CHF 0 and 0 sales for CHF 0, with the latest management transaction recorded on 2024-06-25. The largest declared shareholders by voting rights include JPMorgan Chase & Co. at 53.547%, Santhera Pharmaceuticals Schweiz AG at 45.089% and 41.038% across different positions, and Santhera Pharmaceuticals Holding AG itself at 40.166%.
Insider barometer
90 days
No transaction in this window
Latest transaction
25.06.2024
Largest purchase
CHF 277’493
Largest sale
CHF 9’036
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow Santhera Pharmaceuticals Holding AG’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
Santhera Pharmaceuticals Holding AG insider transactions
Santhera Pharmaceuticals Holding AG
Executive member of the board of directors / senior management · Registered shares
Santhera Pharmaceuticals Holding AG
Executive member of the board of directors / senior management · Registered shares
Latest shareholding disclosures
Santhera Pharmaceuticals Holding AG
BlackRock, Inc · Single shareholder
Santhera Pharmaceuticals Holding AG
UBS Fund Management Switzerland AG · Collective investment vehicle
Santhera Pharmaceuticals Holding AG
BlackRock, Inc · Single shareholder
Santhera Pharmaceuticals Holding AG
BlackRock, Inc · Single shareholder
Santhera Pharmaceuticals Holding AG
Thea Paola + Francesco Angelini · Single shareholder